Concepedia

Katherine Galvin

KG

Statistics

Publications

28

Citations

4.3K

H-Index

22

Active since

1990

Affiliations

Harvard University(Current)

Millennium Engineering and Integration (United States)

Takeda (United States)

Fox Chase Cancer Center

Center for Cancer Research

Katherine Galvin is an author at Harvard University specializing in molecular oncology, oncology, and molecular biology.

Publications per year

1990–2021

28

Publications

28

A role for Smad6 in development and homeostasis of the cardiovascular system

Katherine Galvin, Michael J. Donovan, Catherine Lynch et al. · Nature Genetics · 2000 · 500 citations

Life Sciences, Cell Biology, Molecular Biology +12

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment

Marc L. Hyer, Michael A. Milhollen, Jeff Ciavarri et al. · Nature Medicine · 2018 · 456 citations

Pharmacy, Medicinal Chemistry, Oncology +14

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Katherine Galvin, T. Jake Liang, K. J. Isselbacher et al. · Proceedings of the National Academy of Sciences · 1990 · 417 citations

Medicine, Molecular Biology, Oncology +10

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

Mark Manfredi, Jeffrey Ecsedy, Kristan Meetze et al. · Proceedings of the National Academy of Sciences · 2007 · 413 citations · Full text

Medicine, Oncology, Pharmacology +14

The Human Factors YY1 and LSF Repress the Human Immunodeficiency Virus Type 1 Long Terminal Repeat via Recruitment of Histone Deacetylase 1

Jason J. Coull, Fabio Romerio, Jian-Min Sun et al. · Journal of Virology · 2000 · 346 citations

Life Sciences, Genetics, Molecular Biology +16

1–5 of 28